Huda Mando
Experiences
1- Supervisor on practical aspects of general and organic chemistry at Arab International University/faculty of pharmacy 2013-2020.2- Supervisor on practical aspects of general chemistry at Arab International University/faculty of dentistry 2019-2020.
3- Teaching quality control of pharmaceuticals- theoretical aspects- at Arab International University/faculty of pharmacy 2018-2020.
4- Teaching pharmaceutical chemistry- theoretical aspects- at Arab International University/faculty of pharmacy 2020.
5- Teaching quality control of pharmaceuticals- theoretical aspects- at alkalamoon university/faculty of pharmacy 2018-2019.
6- Supervisor on practical aspects of medicinal and organic chemistry at Damascus University/faculty of pharmacy 2013-2020.
7- Supervisor on practical aspects of quality control of pharmaceuticals at Damascus University/faculty of pharmacy 2019-2020.
8- Supervisor on practical aspects of organic chemistry at Damascus University/biomedical science 2013-2020.
Education
master degree in quality control of pharmaceuticals- faculty of pharmacy-Damascus university 2008.
diploma in quality control of pharmaceuticals- faculty of pharmacy-Damascus university 1996.
Publication
1- MA Al-Khayat, S Haidar, H Mando.Development and validation of RP-HPLC method for determination of clopidogrel in tablets. Int. J. Pharm. Sci. Rev. Res 14, 1-5:2012
2- DEVELOPMENT AND VALIDATION OF RP-HPLC METHOD FOR DETERMINATION OF H Mando, A Hasan.LEVOFLOXACIN IN TABLET USING UV AND FLUORESCENCE DETECTORS SIMELTANIOUSLY. International Journal of Pharmaceutical Sciences and Research 6 (4), 1401-1406:2015
3- H Mando, A Hassan.Identifying Novel Pharmacophore of Nonsteroidal 5-alpha Reductase II Inhibitors and Determining New Inhibitors by Ligand-based Pharmacophore, Virtual Screening, and Molecular modeling. Arab Journalof Pharmaceutical Sciences 6 (4), 74-83: 2020.
4- H Mando, A Hassan, S Gharaghani. Novel and predictive QSAR model for steroidal and nonsteroidal 5α-Reductase type II Inhibitors. Current Drug Discovery Technologies: DOI: 10.2174/1570163817666200324170457 .2020.
5- Mando H., Gharaghani S. Hasan A. A Novel QSAR Model for Prediction of Inhibitory Activity of 4- (1-Benzoylindol-3-yl) Butyric Acid Derivatives Used in Benign Prostate Hypertrophy. Arab Journal of Pharmaceutical Sciences.6(2),67-77:2019.
